Recent advances in prognostication and treatment of polycythemia vera

[Manouche]

« Although the current goals of PV treatment are to alleviate symptoms and reduce thrombotic risk, there are growing efforts to identify disease-modifying agents which will also prevent progression of disease. Here, we give an overview of the developing prognostic tools and therapeutic landscape for PV, focusing on four drug classes: pegylated interferon-alpha 2, MDM2 antagonists, hepcidin mimetics, and histone deacetylase inhibitors. »

« The future of PV treatment likely will require combination treatments, which are being explored in preclinical studies. »

facultyopinions.com/prime/r...

[MPort]

Than you. I appreciate thesee links. I have downloaded PDF for reading at leisure. It brings us hope to know there is this research.

[Turfbeg]

Many thanks for all the links you post for us! I have to admit that I don't always read them with complete understanding but I have stored them for future referral! It's really good to know that so much research is happening. Diolch yn fawr!